INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 125 filers reported holding INTERSECT ENT INC in Q3 2021. The put-call ratio across all filers is 3.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,442,000 | -9.6% | 836,915 | -11.9% | 0.00% | 0.0% |
| Q4 2021 | $25,935,000 | -6.5% | 949,670 | -6.9% | 0.00% | 0.0% |
| Q3 2021 | $27,737,000 | +61.1% | 1,019,732 | +1.2% | 0.00% | 0.0% |
| Q2 2021 | $17,215,000 | -12.0% | 1,007,310 | +7.5% | 0.00% | 0.0% |
| Q1 2021 | $19,572,000 | -2.9% | 937,376 | +6.5% | 0.00% | 0.0% |
| Q4 2020 | $20,155,000 | +75.1% | 880,125 | +24.7% | 0.00% | 0.0% |
| Q3 2020 | $11,512,000 | +5.7% | 705,848 | -12.2% | 0.00% | 0.0% |
| Q2 2020 | $10,887,000 | +27.3% | 804,067 | +11.4% | 0.00% | 0.0% |
| Q1 2020 | $8,550,000 | -51.8% | 721,478 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $17,750,000 | +43.6% | 712,847 | -1.9% | 0.00% | 0.0% |
| Q3 2019 | $12,362,000 | -21.5% | 726,772 | +5.1% | 0.00% | 0.0% |
| Q2 2019 | $15,742,000 | -26.4% | 691,642 | +4.0% | 0.00% | -50.0% |
| Q1 2019 | $21,391,000 | +14.4% | 665,359 | +0.3% | 0.00% | 0.0% |
| Q4 2018 | $18,701,000 | -5.4% | 663,634 | -3.5% | 0.00% | 0.0% |
| Q3 2018 | $19,763,000 | -13.9% | 687,379 | +12.1% | 0.00% | 0.0% |
| Q2 2018 | $22,953,000 | -2.4% | 613,031 | +2.5% | 0.00% | 0.0% |
| Q1 2018 | $23,512,000 | +27.4% | 598,266 | +5.0% | 0.00% | +100.0% |
| Q4 2017 | $18,458,000 | +1.4% | 569,682 | -2.6% | 0.00% | -50.0% |
| Q3 2017 | $18,210,000 | +18.0% | 584,621 | +5.8% | 0.00% | +100.0% |
| Q2 2017 | $15,437,000 | +117.8% | 552,344 | +33.6% | 0.00% | 0.0% |
| Q1 2017 | $7,088,000 | +27.7% | 413,376 | -10.0% | 0.00% | 0.0% |
| Q4 2016 | $5,550,000 | -14.0% | 459,327 | +12.8% | 0.00% | 0.0% |
| Q3 2016 | $6,453,000 | +31.1% | 407,354 | +7.0% | 0.00% | 0.0% |
| Q2 2016 | $4,923,000 | -36.6% | 380,784 | -6.7% | 0.00% | 0.0% |
| Q1 2016 | $7,761,000 | -27.8% | 408,218 | -14.5% | 0.00% | 0.0% |
| Q4 2015 | $10,750,000 | -55.9% | 477,678 | -54.2% | 0.00% | -66.7% |
| Q3 2015 | $24,404,000 | +428.5% | 1,043,185 | +546.8% | 0.00% | – |
| Q2 2015 | $4,618,000 | +163.9% | 161,296 | +137.8% | 0.00% | – |
| Q1 2015 | $1,750,000 | +82.7% | 67,829 | +31.7% | 0.00% | – |
| Q4 2014 | $958,000 | +46.0% | 51,500 | +21.7% | 0.00% | – |
| Q3 2014 | $656,000 | – | 42,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |